Research workbench
2BDJ: Src kinase in complex with inhibitor AP23464
Analyse 2BDJ: Src kinase in complex with inhibitor AP23464 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 2BDJ
- Type
- protein
- Length
- 254 residues
- Chains
- 1
- Method
- x-ray diffraction
- Authors
- Dalgarno, D., Stehle, T., Schelling, P., Narula, S., Sawyer, T.
- Deposited
- 10/20/05
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 2.5
- Source
- Homo sapiens
- Molecule
- Proto-oncogene tyrosine-protein kinase Src
- EC
- 2.7.1.112
- UniProt
- P12931
- Ligands
- HET
- Pockets
- 1 · best druggability 0.68
Structure
x-ray diffraction · resolution 2.5 · 1 distinct chain · 41% helix, 18% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Proto-oncogene tyrosine-protein kinase Src (EC 2.7.1.112) | protein | 254 | 41% helix, 18% strand | P12931 |
Ligands and binding sites
- HET · 3-[2-(2-cyclopentyl-6-{[4-(dimethylphosphoryl)phenyl]amino}-9H-purin-9-yl)ethyl]phenol · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 394 | 0.68 | 0.80 | 40 | HET |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P12931
- Elsewhere: RCSB PDB 2BDJ · PDBe 2BDJ · UniProt P12931
Other records of 2BDJ
- 2BDJ-2 · MolNFT v1 / PDB · Src kinase in complex with inhibitor AP23464
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.